

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuromuscular synaptic transmission (GO:0007274) | 6.61709610 |
| 2 | enteric nervous system development (GO:0048484) | 6.43615444 |
| 3 | sympathetic nervous system development (GO:0048485) | 6.15118400 |
| 4 | positive regulation of fibroblast migration (GO:0010763) | 5.80672508 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.77342335 |
| 6 | intermediate filament organization (GO:0045109) | 5.49159496 |
| 7 | * neurotransmitter secretion (GO:0007269) | 5.47475320 |
| 8 | peripheral nervous system neuron development (GO:0048935) | 5.34384959 |
| 9 | ganglion development (GO:0061548) | 5.30078890 |
| 10 | neurotransmitter biosynthetic process (GO:0042136) | 5.14935347 |
| 11 | negative regulation of heart rate (GO:0010459) | 5.07044726 |
| 12 | neuronal action potential propagation (GO:0019227) | 5.01835792 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.81470499 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.78511872 |
| 15 | skeletal muscle organ development (GO:0060538) | 4.71630112 |
| 16 | respiratory system process (GO:0003016) | 4.70615026 |
| 17 | axon cargo transport (GO:0008088) | 4.63129195 |
| 18 | synaptic vesicle exocytosis (GO:0016079) | 4.60147661 |
| 19 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.56629040 |
| 20 | regulation of glomerular filtration (GO:0003093) | 4.52685922 |
| 21 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.48412527 |
| 22 | diaphragm development (GO:0060539) | 4.44718280 |
| 23 | neuromuscular process controlling posture (GO:0050884) | 4.39287919 |
| 24 | cell migration in hindbrain (GO:0021535) | 4.37981160 |
| 25 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.21415182 |
| 26 | neuron cell-cell adhesion (GO:0007158) | 4.19370774 |
| 27 | behavioral response to ethanol (GO:0048149) | 4.16990478 |
| 28 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.14389014 |
| 29 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.11900983 |
| 30 | negative regulation of microtubule polymerization (GO:0031115) | 4.10506586 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.10264423 |
| 32 | neurotransmitter metabolic process (GO:0042133) | 4.08566211 |
| 33 | adult walking behavior (GO:0007628) | 4.03829954 |
| 34 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.02915866 |
| 35 | sequestering of actin monomers (GO:0042989) | 4.01261090 |
| 36 | synaptic transmission, cholinergic (GO:0007271) | 3.98800429 |
| 37 | protein localization to synapse (GO:0035418) | 3.95827827 |
| 38 | motor neuron axon guidance (GO:0008045) | 3.94686744 |
| 39 | cell communication by electrical coupling (GO:0010644) | 3.94232292 |
| 40 | glutamate secretion (GO:0014047) | 3.87884509 |
| 41 | cranial nerve morphogenesis (GO:0021602) | 3.84862002 |
| 42 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.83481514 |
| 43 | regulation of vesicle fusion (GO:0031338) | 3.82200170 |
| 44 | activation of protein kinase A activity (GO:0034199) | 3.80408189 |
| 45 | * neurotransmitter transport (GO:0006836) | 3.79270539 |
| 46 | * regulation of neurotransmitter levels (GO:0001505) | 3.77602717 |
| 47 | dopaminergic neuron differentiation (GO:0071542) | 3.77243798 |
| 48 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 3.73088760 |
| 49 | regulation of circadian sleep/wake cycle (GO:0042749) | 3.73088760 |
| 50 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.71397636 |
| 51 | renal system process involved in regulation of blood volume (GO:0001977) | 3.65395852 |
| 52 | vocalization behavior (GO:0071625) | 3.65019026 |
| 53 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.64768956 |
| 54 | regulation of cardioblast proliferation (GO:0003264) | 3.63302936 |
| 55 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.63302936 |
| 56 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.58865974 |
| 57 | response to pheromone (GO:0019236) | 3.57988365 |
| 58 | startle response (GO:0001964) | 3.57155476 |
| 59 | type B pancreatic cell development (GO:0003323) | 3.55558308 |
| 60 | ATP synthesis coupled proton transport (GO:0015986) | 3.51670976 |
| 61 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.51670976 |
| 62 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.50989376 |
| 63 | regulation of transmission of nerve impulse (GO:0051969) | 3.48629183 |
| 64 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.43844974 |
| 65 | auditory behavior (GO:0031223) | 3.43510232 |
| 66 | regulation of synaptic vesicle transport (GO:1902803) | 3.41948125 |
| 67 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.41443572 |
| 68 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.40713249 |
| 69 | membrane hyperpolarization (GO:0060081) | 3.39902430 |
| 70 | nucleobase catabolic process (GO:0046113) | 3.38527284 |
| 71 | central nervous system neuron axonogenesis (GO:0021955) | 3.38310094 |
| 72 | neuromuscular process (GO:0050905) | 3.38116109 |
| 73 | negative chemotaxis (GO:0050919) | 3.37759107 |
| 74 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.36573065 |
| 75 | axon extension involved in axon guidance (GO:0048846) | 3.36573065 |
| 76 | regulation of heart morphogenesis (GO:2000826) | 3.36127699 |
| 77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.31915727 |
| 78 | establishment of nucleus localization (GO:0040023) | 3.30718080 |
| 79 | neuromuscular process controlling balance (GO:0050885) | 3.30640430 |
| 80 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.28985977 |
| 81 | regulation of respiratory system process (GO:0044065) | 3.28572411 |
| 82 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.28420814 |
| 83 | intermediate filament cytoskeleton organization (GO:0045104) | 3.27136134 |
| 84 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 3.26237233 |
| 85 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.25096494 |
| 86 | suckling behavior (GO:0001967) | 3.22616531 |
| 87 | locomotory exploration behavior (GO:0035641) | 3.21475446 |
| 88 | dendrite development (GO:0016358) | 3.20723411 |
| 89 | righting reflex (GO:0060013) | 3.19436966 |
| 90 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.19385469 |
| 91 | maternal behavior (GO:0042711) | 3.19140781 |
| 92 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.18907657 |
| 93 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.18907657 |
| 94 | exploration behavior (GO:0035640) | 3.18261419 |
| 95 | layer formation in cerebral cortex (GO:0021819) | 3.15623895 |
| 96 | cell migration involved in heart development (GO:0060973) | 3.14501361 |
| 97 | intermediate filament-based process (GO:0045103) | 3.14253260 |
| 98 | regulation of synapse structural plasticity (GO:0051823) | 3.12456067 |
| 99 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.09916942 |
| 100 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.09882070 |
| 101 | positive regulation of vesicle fusion (GO:0031340) | 3.07803938 |
| 102 | neuron recognition (GO:0008038) | 3.07766877 |
| 103 | circadian sleep/wake cycle process (GO:0022410) | 3.07379845 |
| 104 | axonal fasciculation (GO:0007413) | 3.05989947 |
| 105 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.05199939 |
| 106 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.04170047 |
| 107 | cartilage morphogenesis (GO:0060536) | 3.03525784 |
| 108 | presynaptic membrane organization (GO:0097090) | 3.02752427 |
| 109 | cerebellar Purkinje cell layer development (GO:0021680) | 3.02574909 |
| 110 | lateral sprouting from an epithelium (GO:0060601) | 3.02121561 |
| 111 | negative regulation of neurological system process (GO:0031645) | 3.02022608 |
| 112 | regulation of respiratory gaseous exchange (GO:0043576) | 3.01394672 |
| 113 | dendrite morphogenesis (GO:0048813) | 3.00935191 |
| 114 | rhythmic behavior (GO:0007622) | 2.95925369 |
| 115 | axon extension (GO:0048675) | 2.95739054 |
| 116 | positive regulation of synapse assembly (GO:0051965) | 2.95523661 |
| 117 | dendritic spine organization (GO:0097061) | 2.95460369 |
| 118 | dendritic spine morphogenesis (GO:0060997) | 2.95083852 |
| 119 | peristalsis (GO:0030432) | 2.93537986 |
| 120 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.93500923 |
| 121 | cardiac ventricle formation (GO:0003211) | 2.93138073 |
| 122 | respiratory electron transport chain (GO:0022904) | 2.92172413 |
| 123 | positive regulation of glomerulus development (GO:0090193) | 2.90637044 |
| 124 | behavioral response to nicotine (GO:0035095) | 2.89757163 |
| 125 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.88375030 |
| 126 | lateral ventricle development (GO:0021670) | 2.85512533 |
| 127 | regulation of axonogenesis (GO:0050770) | 2.85357170 |
| 128 | transmission of nerve impulse (GO:0019226) | 2.85341328 |
| 129 | regulation of vasodilation (GO:0042312) | 2.83709780 |
| 130 | electron transport chain (GO:0022900) | 2.83546132 |
| 131 | response to auditory stimulus (GO:0010996) | 2.83039185 |
| 132 | postsynaptic membrane organization (GO:0001941) | 2.79704298 |
| 133 | * signal release (GO:0023061) | 2.79183505 |
| 134 | neuron-neuron synaptic transmission (GO:0007270) | 2.77284491 |
| 135 | establishment of mitochondrion localization (GO:0051654) | 2.76415522 |
| 136 | dopamine receptor signaling pathway (GO:0007212) | 2.75299694 |
| 137 | parental behavior (GO:0060746) | 2.74376705 |
| 138 | cardiac chamber formation (GO:0003207) | 2.72821570 |
| 139 | synapse assembly (GO:0007416) | 2.72674098 |
| 140 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.72257217 |
| 141 | regulation of axon guidance (GO:1902667) | 2.71428782 |
| 142 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.68548919 |
| 143 | body morphogenesis (GO:0010171) | 2.68412532 |
| 144 | neural crest cell migration (GO:0001755) | 2.66216344 |
| 145 | dorsal/ventral neural tube patterning (GO:0021904) | 2.66147003 |
| 146 | innervation (GO:0060384) | 2.66052455 |
| 147 | glandular epithelial cell development (GO:0002068) | 2.61794561 |
| 148 | endocardial cushion morphogenesis (GO:0003203) | 2.60683628 |
| 149 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.59048395 |
| 150 | negative regulation of axon guidance (GO:1902668) | 2.56788791 |
| 151 | urinary tract smooth muscle contraction (GO:0014848) | 2.56328488 |
| 152 | mesenchyme morphogenesis (GO:0072132) | 2.55534540 |
| 153 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.55319025 |
| 154 | embryonic body morphogenesis (GO:0010172) | 2.52051284 |
| 155 | catecholamine biosynthetic process (GO:0042423) | 2.50731055 |
| 156 | catechol-containing compound biosynthetic process (GO:0009713) | 2.50731055 |
| 157 | response to pain (GO:0048265) | 2.50306412 |
| 158 | retinal ganglion cell axon guidance (GO:0031290) | 2.50072008 |
| 159 | cranial nerve development (GO:0021545) | 2.49535770 |
| 160 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.49411995 |
| 161 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.48828854 |
| 162 | camera-type eye morphogenesis (GO:0048593) | 2.48644679 |
| 163 | neuron fate specification (GO:0048665) | 2.47975724 |
| 164 | positive regulation of axon extension (GO:0045773) | 2.47376087 |
| 165 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.47044897 |
| 166 | neural crest cell development (GO:0014032) | 2.45542224 |
| 167 | regulation of dendrite morphogenesis (GO:0048814) | 2.42857617 |
| 168 | synapse organization (GO:0050808) | 2.42627601 |
| 169 | neurofilament cytoskeleton organization (GO:0060052) | 11.6628324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.80215728 |
| 2 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 3.42858465 |
| 3 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.39119357 |
| 4 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 3.27843121 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.20166334 |
| 6 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 3.07143419 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 3.07143419 |
| 8 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.84931260 |
| 9 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.83881375 |
| 10 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.73258850 |
| 11 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.69673512 |
| 12 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.69227507 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.67498662 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.66147135 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.66008619 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65604465 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.61107091 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.58094803 |
| 19 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55286684 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.54892348 |
| 21 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.54030771 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.52675397 |
| 23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.42093232 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.38887682 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.35204571 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.32898170 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.20108734 |
| 28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19651877 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16156247 |
| 30 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.07027508 |
| 31 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.06846077 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.99745695 |
| 33 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.94376528 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90328622 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.80183131 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78635885 |
| 37 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.76579739 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72556193 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72392284 |
| 40 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.71413159 |
| 41 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.67665329 |
| 42 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.67665329 |
| 43 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.67665329 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.67333820 |
| 45 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.64928177 |
| 46 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.63877763 |
| 47 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.62852465 |
| 48 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.61893904 |
| 49 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.52158992 |
| 50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.45780398 |
| 51 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.45495474 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.45181405 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41098045 |
| 54 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.39837451 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36751122 |
| 56 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.35470224 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31481189 |
| 58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30362216 |
| 59 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.28984661 |
| 60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28340953 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28104099 |
| 62 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.26414583 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26384589 |
| 64 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25587179 |
| 65 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.25211034 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25012469 |
| 67 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24962898 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22649331 |
| 69 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.19274889 |
| 70 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17850564 |
| 71 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.17377576 |
| 72 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.16266071 |
| 73 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.15281768 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13711255 |
| 75 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.12308867 |
| 76 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11463834 |
| 77 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07374378 |
| 78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.06772076 |
| 79 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04734321 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03389378 |
| 81 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00304190 |
| 82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99673798 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97854144 |
| 84 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97751035 |
| 85 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.97065294 |
| 86 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.97025136 |
| 87 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95754852 |
| 88 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93956097 |
| 89 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93777318 |
| 90 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93469350 |
| 91 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93102816 |
| 92 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92776227 |
| 93 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91649444 |
| 94 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91405951 |
| 95 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.91320419 |
| 96 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89451206 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88966954 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88521970 |
| 99 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87293828 |
| 100 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.87145460 |
| 101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86784344 |
| 102 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86582273 |
| 103 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86382432 |
| 104 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85662609 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84964192 |
| 106 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84753506 |
| 107 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.84098413 |
| 108 | * AR_19668381_ChIP-Seq_PC3_Human | 0.83796463 |
| 109 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82463742 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80547113 |
| 111 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.80411152 |
| 112 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80100571 |
| 113 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.79321952 |
| 114 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79154424 |
| 115 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.78985404 |
| 116 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.78574852 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78440391 |
| 118 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.78268509 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78144815 |
| 120 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.78095084 |
| 121 | P300_19829295_ChIP-Seq_ESCs_Human | 0.77672639 |
| 122 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.77634192 |
| 123 | AR_25329375_ChIP-Seq_VCAP_Human | 0.77531246 |
| 124 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.77079257 |
| 125 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.76494553 |
| 126 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.75866240 |
| 127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.75141421 |
| 128 | P68_20966046_ChIP-Seq_HELA_Human | 0.74407748 |
| 129 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.73744415 |
| 130 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73693542 |
| 131 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.72695851 |
| 132 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.72232177 |
| 133 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.71529280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.22245037 |
| 2 | MP0003880_abnormal_central_pattern | 4.14791555 |
| 3 | MP0005423_abnormal_somatic_nervous | 3.99688669 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 3.86778686 |
| 5 | MP0009046_muscle_twitch | 3.29923910 |
| 6 | * MP0000955_abnormal_spinal_cord | 3.24664880 |
| 7 | MP0004270_analgesia | 3.19284113 |
| 8 | * MP0002184_abnormal_innervation | 3.16881519 |
| 9 | * MP0004142_abnormal_muscle_tone | 3.16183671 |
| 10 | MP0002272_abnormal_nervous_system | 2.81448558 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.80191813 |
| 12 | * MP0009745_abnormal_behavioral_response | 2.77009229 |
| 13 | * MP0002063_abnormal_learning/memory/cond | 2.69592008 |
| 14 | * MP0002064_seizures | 2.67695902 |
| 15 | MP0001188_hyperpigmentation | 2.54230577 |
| 16 | MP0006276_abnormal_autonomic_nervous | 2.48164283 |
| 17 | MP0002102_abnormal_ear_morphology | 2.37452155 |
| 18 | MP0001529_abnormal_vocalization | 2.34059713 |
| 19 | MP0003329_amyloid_beta_deposits | 2.33897163 |
| 20 | MP0005409_darkened_coat_color | 2.25499321 |
| 21 | MP0001486_abnormal_startle_reflex | 2.24003896 |
| 22 | MP0004811_abnormal_neuron_physiology | 2.21642743 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.13404192 |
| 24 | MP0000778_abnormal_nervous_system | 2.10732228 |
| 25 | MP0003011_delayed_dark_adaptation | 2.06681996 |
| 26 | MP0003136_yellow_coat_color | 2.01151908 |
| 27 | MP0001970_abnormal_pain_threshold | 1.99412164 |
| 28 | * MP0002882_abnormal_neuron_morphology | 1.92984390 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.86650832 |
| 30 | MP0003122_maternal_imprinting | 1.84422041 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.82266126 |
| 32 | MP0008569_lethality_at_weaning | 1.81549865 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.80345122 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.78831715 |
| 35 | MP0002067_abnormal_sensory_capabilities | 1.72107495 |
| 36 | MP0000534_abnormal_ureter_morphology | 1.67983904 |
| 37 | MP0004858_abnormal_nervous_system | 1.65305477 |
| 38 | MP0000566_synostosis | 1.64400218 |
| 39 | MP0001177_atelectasis | 1.64143420 |
| 40 | * MP0002752_abnormal_somatic_nervous | 1.62331249 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.60656526 |
| 42 | * MP0002557_abnormal_social/conspecific_i | 1.56412072 |
| 43 | MP0005187_abnormal_penis_morphology | 1.53972308 |
| 44 | MP0005623_abnormal_meninges_morphology | 1.53911292 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.51138876 |
| 46 | MP0004924_abnormal_behavior | 1.49796534 |
| 47 | MP0005386_behavior/neurological_phenoty | 1.49796534 |
| 48 | * MP0002066_abnormal_motor_capabilities/c | 1.46280691 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.43178304 |
| 50 | MP0005503_abnormal_tendon_morphology | 1.42948766 |
| 51 | MP0000537_abnormal_urethra_morphology | 1.40918721 |
| 52 | MP0000751_myopathy | 1.40086792 |
| 53 | MP0002009_preneoplasia | 1.39971109 |
| 54 | MP0003787_abnormal_imprinting | 1.39567623 |
| 55 | MP0002229_neurodegeneration | 1.36652025 |
| 56 | MP0002735_abnormal_chemical_nociception | 1.35565404 |
| 57 | MP0009053_abnormal_anal_canal | 1.29012010 |
| 58 | MP0005275_abnormal_skin_tensile | 1.24928617 |
| 59 | MP0002932_abnormal_joint_morphology | 1.21451590 |
| 60 | MP0002736_abnormal_nociception_after | 1.20094877 |
| 61 | MP0010030_abnormal_orbit_morphology | 1.19096655 |
| 62 | MP0005646_abnormal_pituitary_gland | 1.17922037 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.16797214 |
| 64 | MP0009250_abnormal_appendicular_skeleto | 1.14945018 |
| 65 | MP0000678_abnormal_parathyroid_gland | 1.14426817 |
| 66 | MP0002152_abnormal_brain_morphology | 1.14340367 |
| 67 | MP0002822_catalepsy | 1.13299411 |
| 68 | MP0003567_abnormal_fetal_cardiomyocyte | 1.11185178 |
| 69 | MP0001943_abnormal_respiration | 1.09919052 |
| 70 | MP0000604_amyloidosis | 1.08012183 |
| 71 | MP0003634_abnormal_glial_cell | 1.07778208 |
| 72 | MP0003385_abnormal_body_wall | 1.05786056 |
| 73 | MP0005197_abnormal_uvea_morphology | 1.05743290 |
| 74 | MP0004885_abnormal_endolymph | 1.05380498 |
| 75 | MP0000049_abnormal_middle_ear | 1.05148522 |
| 76 | MP0001299_abnormal_eye_distance/ | 1.04899286 |
| 77 | MP0003942_abnormal_urinary_system | 1.04375348 |
| 78 | MP0002108_abnormal_muscle_morphology | 1.03811474 |
| 79 | MP0003633_abnormal_nervous_system | 1.03708609 |
| 80 | MP0003631_nervous_system_phenotype | 1.02514118 |
| 81 | MP0003121_genomic_imprinting | 0.99130063 |
| 82 | MP0002751_abnormal_autonomic_nervous | 0.98536534 |
| 83 | MP0003119_abnormal_digestive_system | 0.97617133 |
| 84 | MP0000538_abnormal_urinary_bladder | 0.97472202 |
| 85 | MP0000579_abnormal_nail_morphology | 0.96971918 |
| 86 | MP0003861_abnormal_nervous_system | 0.95399630 |
| 87 | MP0003879_abnormal_hair_cell | 0.89702997 |
| 88 | MP0002282_abnormal_trachea_morphology | 0.89636937 |
| 89 | MP0001984_abnormal_olfaction | 0.89550049 |
| 90 | * MP0003948_abnormal_gas_homeostasis | 0.89218831 |
| 91 | MP0000428_abnormal_craniofacial_morphol | 0.88301042 |
| 92 | MP0004085_abnormal_heartbeat | 0.87286051 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.87008675 |
| 94 | MP0003878_abnormal_ear_physiology | 0.87008675 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.85239951 |
| 96 | MP0002638_abnormal_pupillary_reflex | 0.84584927 |
| 97 | MP0002249_abnormal_larynx_morphology | 0.84492457 |
| 98 | MP0003283_abnormal_digestive_organ | 0.83342272 |
| 99 | MP0005551_abnormal_eye_electrophysiolog | 0.83271441 |
| 100 | MP0003632_abnormal_nervous_system | 0.81671552 |
| 101 | MP0003755_abnormal_palate_morphology | 0.81577704 |
| 102 | MP0002697_abnormal_eye_size | 0.80977719 |
| 103 | MP0005367_renal/urinary_system_phenotyp | 0.79861062 |
| 104 | MP0000516_abnormal_urinary_system | 0.79861062 |
| 105 | MP0003937_abnormal_limbs/digits/tail_de | 0.78918180 |
| 106 | MP0003705_abnormal_hypodermis_morpholog | 0.78135164 |
| 107 | MP0005394_taste/olfaction_phenotype | 0.77940210 |
| 108 | MP0005499_abnormal_olfactory_system | 0.77940210 |
| 109 | MP0001340_abnormal_eyelid_morphology | 0.77935481 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.77879489 |
| 111 | MP0001502_abnormal_circadian_rhythm | 0.77411472 |
| 112 | * MP0002081_perinatal_lethality | 0.76905132 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.76034212 |
| 114 | MP0010770_preweaning_lethality | 0.75434314 |
| 115 | MP0002082_postnatal_lethality | 0.75434314 |
| 116 | MP0002069_abnormal_eating/drinking_beha | 0.75082840 |
| 117 | MP0005645_abnormal_hypothalamus_physiol | 0.75055454 |
| 118 | * MP0002269_muscular_atrophy | 0.74833484 |
| 119 | MP0002116_abnormal_craniofacial_bone | 0.74794002 |
| 120 | MP0003935_abnormal_craniofacial_develop | 0.74744537 |
| 121 | MP0002127_abnormal_cardiovascular_syste | 0.74645602 |
| 122 | MP0000920_abnormal_myelination | 0.74522910 |
| 123 | MP0010769_abnormal_survival | 0.71922828 |
| 124 | MP0004742_abnormal_vestibular_system | 0.71547077 |
| 125 | MP0001905_abnormal_dopamine_level | 0.71189497 |
| 126 | MP0002277_abnormal_respiratory_mucosa | 0.70879637 |
| 127 | MP0000631_abnormal_neuroendocrine_gland | 0.70459056 |
| 128 | MP0003123_paternal_imprinting | 0.68124214 |
| 129 | MP0010768_mortality/aging | 0.67386851 |
| 130 | * MP0000759_abnormal_skeletal_muscle | 0.66225123 |
| 131 | MP0001879_abnormal_lymphatic_vessel | 0.66213538 |
| 132 | MP0001963_abnormal_hearing_physiology | 0.64892243 |
| 133 | MP0009780_abnormal_chondrocyte_physiolo | 0.63666647 |
| 134 | MP0004272_abnormal_basement_membrane | 0.63656361 |
| 135 | MP0005253_abnormal_eye_physiology | 0.63463416 |
| 136 | MP0001348_abnormal_lacrimal_gland | 0.63396866 |
| 137 | MP0005410_abnormal_fertilization | 0.60720769 |
| 138 | MP0001270_distended_abdomen | 0.58395651 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.56615860 |
| 140 | * MP0002114_abnormal_axial_skeleton | 0.54594707 |
| 141 | MP0001664_abnormal_digestion | 0.53872568 |
| 142 | MP0004197_abnormal_fetal_growth/weight/ | 0.53586557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.99826609 |
| 2 | Poor suck (HP:0002033) | 5.77939319 |
| 3 | Septate vagina (HP:0001153) | 5.76403392 |
| 4 | Abnormality of the vocal cords (HP:0008777) | 5.03489644 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 4.53579704 |
| 6 | Pheochromocytoma (HP:0002666) | 4.43813377 |
| 7 | Generalized hypotonia (HP:0001290) | 4.15724443 |
| 8 | Hypothermia (HP:0002045) | 4.13244176 |
| 9 | Rectal fistula (HP:0100590) | 4.01376112 |
| 10 | Rectovaginal fistula (HP:0000143) | 4.01376112 |
| 11 | Ulnar claw (HP:0001178) | 3.99322725 |
| 12 | Bicornuate uterus (HP:0000813) | 3.86477261 |
| 13 | Neuroendocrine neoplasm (HP:0100634) | 3.81062724 |
| 14 | Ankle clonus (HP:0011448) | 3.71714066 |
| 15 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.69868919 |
| 16 | Focal seizures (HP:0007359) | 3.55377124 |
| 17 | Vaginal fistula (HP:0004320) | 3.55177146 |
| 18 | Intestinal fistula (HP:0100819) | 3.53823527 |
| 19 | Type 2 muscle fiber atrophy (HP:0003554) | 3.43763277 |
| 20 | Focal motor seizures (HP:0011153) | 3.28704278 |
| 21 | Neonatal hypoglycemia (HP:0001998) | 3.24253311 |
| 22 | Atonic seizures (HP:0010819) | 3.20510549 |
| 23 | Neoplasm of the peripheral nervous system (HP:0100007) | 3.19506975 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.17155306 |
| 25 | Febrile seizures (HP:0002373) | 3.05667715 |
| 26 | Lower limb asymmetry (HP:0100559) | 2.98087584 |
| 27 | Failure to thrive in infancy (HP:0001531) | 2.91417669 |
| 28 | Action tremor (HP:0002345) | 2.90660231 |
| 29 | Muscle fiber atrophy (HP:0100295) | 2.89180836 |
| 30 | Exotropia (HP:0000577) | 2.88433923 |
| 31 | Shallow orbits (HP:0000586) | 2.85118839 |
| 32 | Fatigable weakness (HP:0003473) | 2.80802294 |
| 33 | Abnormality of the neuromuscular junction (HP:0003398) | 2.80802294 |
| 34 | Turricephaly (HP:0000262) | 2.80737005 |
| 35 | Urinary urgency (HP:0000012) | 2.72289581 |
| 36 | Progressive external ophthalmoplegia (HP:0000590) | 2.67390509 |
| 37 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.65314261 |
| 38 | Partial agenesis of the corpus callosum (HP:0001338) | 2.64031353 |
| 39 | Anxiety (HP:0000739) | 2.63548609 |
| 40 | Abnormality of the corticospinal tract (HP:0002492) | 2.61431832 |
| 41 | Spastic gait (HP:0002064) | 2.56257397 |
| 42 | Orthostatic hypotension (HP:0001278) | 2.55780242 |
| 43 | Hammertoe (HP:0001765) | 2.53873777 |
| 44 | Bowel diverticulosis (HP:0005222) | 2.52668958 |
| 45 | Hypercortisolism (HP:0001578) | 2.52479205 |
| 46 | Amblyopia (HP:0000646) | 2.49753448 |
| 47 | Visual hallucinations (HP:0002367) | 2.49170042 |
| 48 | Mutism (HP:0002300) | 2.48645760 |
| 49 | Torticollis (HP:0000473) | 2.46564339 |
| 50 | Absence seizures (HP:0002121) | 2.46120517 |
| 51 | Polyphagia (HP:0002591) | 2.45622009 |
| 52 | Premature rupture of membranes (HP:0001788) | 2.45142822 |
| 53 | Epileptic encephalopathy (HP:0200134) | 2.41278123 |
| 54 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.36351035 |
| 55 | Neoplasm of the heart (HP:0100544) | 2.35002851 |
| 56 | Bulbar palsy (HP:0001283) | 2.33543359 |
| 57 | Generalized tonic-clonic seizures (HP:0002069) | 2.33444406 |
| 58 | Asymmetric growth (HP:0100555) | 2.32795979 |
| 59 | Buphthalmos (HP:0000557) | 2.30784637 |
| 60 | Depression (HP:0000716) | 2.27564199 |
| 61 | Abnormality of the lower motor neuron (HP:0002366) | 2.27522635 |
| 62 | Hypoplastic pelvis (HP:0008839) | 2.25183059 |
| 63 | Cortical dysplasia (HP:0002539) | 2.25076188 |
| 64 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.24886412 |
| 65 | Short 4th metacarpal (HP:0010044) | 2.24886412 |
| 66 | Hyperparathyroidism (HP:0000843) | 2.24497566 |
| 67 | Abnormal eating behavior (HP:0100738) | 2.21690567 |
| 68 | Germ cell neoplasia (HP:0100728) | 2.20559186 |
| 69 | Abnormality of the 4th metacarpal (HP:0010012) | 2.20214462 |
| 70 | Dysdiadochokinesis (HP:0002075) | 2.16335430 |
| 71 | Broad metatarsal (HP:0001783) | 2.16190136 |
| 72 | Calcaneovalgus deformity (HP:0001848) | 2.15286513 |
| 73 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.14724877 |
| 74 | Craniofacial dystonia (HP:0012179) | 2.14592006 |
| 75 | Anal stenosis (HP:0002025) | 2.14559955 |
| 76 | Decreased motor nerve conduction velocity (HP:0003431) | 2.14434668 |
| 77 | Incomplete penetrance (HP:0003829) | 2.14367633 |
| 78 | Occipital encephalocele (HP:0002085) | 2.12906168 |
| 79 | Abnormality of the calcaneus (HP:0008364) | 2.12790495 |
| 80 | Thin bony cortex (HP:0002753) | 2.11994013 |
| 81 | Insomnia (HP:0100785) | 2.11929134 |
| 82 | Acute necrotizing encephalopathy (HP:0006965) | 2.11442569 |
| 83 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.11042269 |
| 84 | Paraplegia (HP:0010550) | 2.10677705 |
| 85 | Decreased lacrimation (HP:0000633) | 2.10647626 |
| 86 | Morphological abnormality of the middle ear (HP:0008609) | 2.09806851 |
| 87 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.09339980 |
| 88 | Hypoplasia of the brainstem (HP:0002365) | 2.09339980 |
| 89 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.09289780 |
| 90 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.08765145 |
| 91 | Long toe (HP:0010511) | 2.08561874 |
| 92 | Spastic paraplegia (HP:0001258) | 2.08224367 |
| 93 | Distal sensory impairment (HP:0002936) | 2.08008688 |
| 94 | Dialeptic seizures (HP:0011146) | 2.07506877 |
| 95 | Entropion (HP:0000621) | 2.07080555 |
| 96 | Hypokinesia (HP:0002375) | 2.06589995 |
| 97 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.06124618 |
| 98 | Heterotopia (HP:0002282) | 2.05615002 |
| 99 | Dysmetria (HP:0001310) | 2.05114321 |
| 100 | Severe Myopia (HP:0011003) | 2.04686949 |
| 101 | Foot dorsiflexor weakness (HP:0009027) | 2.04459893 |
| 102 | Delayed gross motor development (HP:0002194) | 2.04066844 |
| 103 | Focal dystonia (HP:0004373) | 2.01990450 |
| 104 | Abnormality of pain sensation (HP:0010832) | 2.01888762 |
| 105 | Impaired pain sensation (HP:0007328) | 2.01888762 |
| 106 | Partial duplication of the phalanx of hand (HP:0009999) | 2.00714296 |
| 107 | Termporal pattern (HP:0011008) | 1.99076238 |
| 108 | Insidious onset (HP:0003587) | 1.99076238 |
| 109 | Soft skin (HP:0000977) | 1.97642270 |
| 110 | Cutaneous finger syndactyly (HP:0010554) | 1.97557894 |
| 111 | Agitation (HP:0000713) | 1.97237008 |
| 112 | Muscle stiffness (HP:0003552) | 1.95744391 |
| 113 | Ventricular fibrillation (HP:0001663) | 1.95521459 |
| 114 | Thyroid carcinoma (HP:0002890) | 1.95446441 |
| 115 | Renal duplication (HP:0000075) | 1.95265505 |
| 116 | Upper limb muscle weakness (HP:0003484) | 1.94906530 |
| 117 | Megalencephaly (HP:0001355) | 1.94188770 |
| 118 | Weak cry (HP:0001612) | 1.94040995 |
| 119 | Lower limb muscle weakness (HP:0007340) | 1.93360725 |
| 120 | Slow saccadic eye movements (HP:0000514) | 1.92688190 |
| 121 | Increased mean platelet volume (HP:0011877) | 1.92678912 |
| 122 | Abnormality of the musculature of the hand (HP:0001421) | 1.92478846 |
| 123 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.92404904 |
| 124 | Limb dystonia (HP:0002451) | 1.91864557 |
| 125 | Drooling (HP:0002307) | 1.91238122 |
| 126 | Adducted thumb (HP:0001181) | 1.91006855 |
| 127 | Pachygyria (HP:0001302) | 1.90604831 |
| 128 | Clonus (HP:0002169) | 1.89673702 |
| 129 | Hypoventilation (HP:0002791) | 1.89166822 |
| 130 | Amyotrophic lateral sclerosis (HP:0007354) | 1.89153258 |
| 131 | Mitochondrial inheritance (HP:0001427) | 1.87737816 |
| 132 | Abnormality of the foot musculature (HP:0001436) | 1.87421127 |
| 133 | Deformed tarsal bones (HP:0008119) | 1.85922165 |
| 134 | Progressive macrocephaly (HP:0004481) | 1.85728146 |
| 135 | Cortical visual impairment (HP:0100704) | 1.85720518 |
| 136 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.83148155 |
| 137 | Pointed chin (HP:0000307) | 1.82712607 |
| 138 | Fetal akinesia sequence (HP:0001989) | 1.82418161 |
| 139 | Aqueductal stenosis (HP:0002410) | 1.82158640 |
| 140 | Abnormality of the metopic suture (HP:0005556) | 1.82120237 |
| 141 | EEG with generalized epileptiform discharges (HP:0011198) | 1.81405632 |
| 142 | Truncal ataxia (HP:0002078) | 1.80171527 |
| 143 | Impaired social interactions (HP:0000735) | 1.79555729 |
| 144 | Abnormal social behavior (HP:0012433) | 1.79555729 |
| 145 | Annular pancreas (HP:0001734) | 1.78786860 |
| 146 | Prominent metopic ridge (HP:0005487) | 1.78424798 |
| 147 | Epileptiform EEG discharges (HP:0011182) | 1.76244123 |
| 148 | Hypsarrhythmia (HP:0002521) | 1.76221187 |
| 149 | Lissencephaly (HP:0001339) | 1.75818500 |
| 150 | Cutaneous syndactyly (HP:0012725) | 1.74507386 |
| 151 | Myelomeningocele (HP:0002475) | 1.73022299 |
| 152 | Midline defect of the nose (HP:0004122) | 1.71149557 |
| 153 | Disproportionate tall stature (HP:0001519) | 1.69962124 |
| 154 | Abnormality of the parietal bone (HP:0002696) | 1.69788924 |
| 155 | Asymmetry of the thorax (HP:0001555) | 1.69725300 |
| 156 | Hyperacusis (HP:0010780) | 1.67858155 |
| 157 | Aortic dissection (HP:0002647) | 1.67068633 |
| 158 | Excessive salivation (HP:0003781) | 1.65184506 |
| 159 | Renal dysplasia (HP:0000110) | 1.64093478 |
| 160 | Hypoplasia of the iris (HP:0007676) | 1.63653428 |
| 161 | Short humerus (HP:0005792) | 1.63218258 |
| 162 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.61175836 |
| 163 | Neuroblastoma (HP:0003006) | 1.60564702 |
| 164 | Primitive neuroectodermal tumor (HP:0030065) | 1.60564702 |
| 165 | Neuroblastic tumors (HP:0004376) | 1.60564702 |
| 166 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.60564702 |
| 167 | Bladder diverticulum (HP:0000015) | 1.60335304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 6.43171136 |
| 2 | MINK1 | 5.18859682 |
| 3 | STK16 | 4.52965510 |
| 4 | LIMK1 | 3.49172983 |
| 5 | MAP3K12 | 3.25420199 |
| 6 | EPHB2 | 2.90510932 |
| 7 | MAP3K9 | 2.78731517 |
| 8 | NTRK3 | 2.77731338 |
| 9 | MAP3K4 | 2.55956143 |
| 10 | EPHA3 | 2.28655043 |
| 11 | TESK2 | 2.08118349 |
| 12 | IRAK3 | 1.94511537 |
| 13 | MAP2K7 | 1.93821360 |
| 14 | NTRK2 | 1.93442904 |
| 15 | PLK4 | 1.89904486 |
| 16 | PRKCG | 1.81916563 |
| 17 | NEK1 | 1.80310597 |
| 18 | MAP2K4 | 1.79178107 |
| 19 | LMTK2 | 1.68969317 |
| 20 | TESK1 | 1.68045054 |
| 21 | PAK6 | 1.66178922 |
| 22 | PKN2 | 1.64421809 |
| 23 | EPHA4 | 1.60878366 |
| 24 | PHKG1 | 1.59898169 |
| 25 | PHKG2 | 1.59898169 |
| 26 | IRAK2 | 1.58504483 |
| 27 | CAMK2G | 1.56901539 |
| 28 | CASK | 1.56581768 |
| 29 | PTK2 | 1.55002990 |
| 30 | MAPK13 | 1.50448975 |
| 31 | LATS2 | 1.43670240 |
| 32 | ILK | 1.39403552 |
| 33 | TRIB3 | 1.29719326 |
| 34 | GRK5 | 1.28758426 |
| 35 | NME1 | 1.28743832 |
| 36 | UHMK1 | 1.27817473 |
| 37 | PAK3 | 1.25330266 |
| 38 | CDK19 | 1.23878593 |
| 39 | DYRK1B | 1.23063194 |
| 40 | DAPK2 | 1.22663863 |
| 41 | CDK5 | 1.21037995 |
| 42 | MYLK | 1.20637365 |
| 43 | CAMKK1 | 1.19818454 |
| 44 | PASK | 1.18826896 |
| 45 | PRKCZ | 1.18084471 |
| 46 | SRPK1 | 1.15837815 |
| 47 | KSR2 | 1.15245289 |
| 48 | KSR1 | 1.12719084 |
| 49 | DMPK | 1.07191994 |
| 50 | PKN1 | 1.05874616 |
| 51 | WNK1 | 1.04182732 |
| 52 | TRIM28 | 1.02918655 |
| 53 | SCYL2 | 0.99380442 |
| 54 | CAMK2A | 0.98254214 |
| 55 | DYRK2 | 0.97690833 |
| 56 | DAPK1 | 0.97625697 |
| 57 | GRK7 | 0.96078981 |
| 58 | PRKCE | 0.94230272 |
| 59 | MATK | 0.93234948 |
| 60 | PLK2 | 0.91220273 |
| 61 | CDK14 | 0.90835186 |
| 62 | STK38L | 0.90401562 |
| 63 | IRAK1 | 0.90212368 |
| 64 | CAMK1G | 0.90133132 |
| 65 | MAP3K11 | 0.86388482 |
| 66 | ROCK2 | 0.82633551 |
| 67 | TTN | 0.80652147 |
| 68 | CDK18 | 0.80637380 |
| 69 | CDK15 | 0.80518736 |
| 70 | PINK1 | 0.79843484 |
| 71 | CAMK2B | 0.79072882 |
| 72 | SGK223 | 0.79047748 |
| 73 | SGK494 | 0.79047748 |
| 74 | CDC42BPA | 0.78432486 |
| 75 | RET | 0.78385267 |
| 76 | ALK | 0.78172999 |
| 77 | STK38 | 0.78140556 |
| 78 | MAP4K2 | 0.78071043 |
| 79 | ERBB2 | 0.77345510 |
| 80 | SIK2 | 0.76815178 |
| 81 | PDGFRA | 0.76323503 |
| 82 | ICK | 0.75531452 |
| 83 | CSNK1A1L | 0.75107224 |
| 84 | FES | 0.73002715 |
| 85 | BCR | 0.71523670 |
| 86 | MAP3K6 | 0.71376196 |
| 87 | NTRK1 | 0.70565219 |
| 88 | DYRK3 | 0.69998048 |
| 89 | CDK11A | 0.69986287 |
| 90 | PRKCI | 0.69074621 |
| 91 | INSRR | 0.67295707 |
| 92 | DDR2 | 0.64279106 |
| 93 | TAOK1 | 0.59838010 |
| 94 | FER | 0.58863674 |
| 95 | PTK6 | 0.57926364 |
| 96 | PRKD3 | 0.57818465 |
| 97 | CAMKK2 | 0.57052746 |
| 98 | ADRBK1 | 0.56303495 |
| 99 | CAMK2D | 0.54699593 |
| 100 | CDK3 | 0.53624435 |
| 101 | CSNK1G1 | 0.52896808 |
| 102 | WNK3 | 0.51762895 |
| 103 | PRPF4B | 0.51013916 |
| 104 | WNK4 | 0.50968116 |
| 105 | PAK2 | 0.50811169 |
| 106 | DYRK1A | 0.50528335 |
| 107 | CSNK1E | 0.49632108 |
| 108 | FGFR2 | 0.49521666 |
| 109 | STK39 | 0.46995577 |
| 110 | ERBB3 | 0.46139870 |
| 111 | ROCK1 | 0.45982093 |
| 112 | RPS6KA2 | 0.45932605 |
| 113 | MET | 0.45534890 |
| 114 | TNIK | 0.43147190 |
| 115 | PRKCH | 0.43075973 |
| 116 | CSNK1G2 | 0.42390020 |
| 117 | PNCK | 0.42324674 |
| 118 | TYRO3 | 0.41676004 |
| 119 | MTOR | 0.41410465 |
| 120 | DAPK3 | 0.41247200 |
| 121 | BRSK1 | 0.41018783 |
| 122 | MARK2 | 0.39895705 |
| 123 | CSNK1A1 | 0.39117549 |
| 124 | MKNK1 | 0.38822327 |
| 125 | MAP2K1 | 0.38631808 |
| 126 | SGK2 | 0.37997441 |
| 127 | MAPK4 | 0.36701010 |
| 128 | PRKCB | 0.35584954 |
| 129 | PRKG1 | 0.35348463 |
| 130 | CSNK1G3 | 0.34962202 |
| 131 | SRC | 0.34316027 |
| 132 | PRKDC | 0.34013561 |
| 133 | STK11 | 0.32632914 |
| 134 | MAPK8 | 0.31693161 |
| 135 | IRAK4 | 0.31557851 |
| 136 | MUSK | 0.29433400 |
| 137 | MAP3K2 | 0.29351767 |
| 138 | PRKACB | 0.26569022 |
| 139 | FYN | 0.26562357 |
| 140 | PRKACA | 0.26511413 |
| 141 | MAPK9 | 0.26142174 |
| 142 | AKT3 | 0.24989729 |
| 143 | PRKCD | 0.23723852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.45255335 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.96262747 |
| 3 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.96202624 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.83215536 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.54134312 |
| 6 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.37462766 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.37360454 |
| 8 | * Cholinergic synapse_Homo sapiens_hsa04725 | 2.31564368 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.22421737 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.07776879 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.04434554 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.02595953 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.98573051 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.96120177 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.94911129 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.87248741 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.84503899 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84321136 |
| 19 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.79311748 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.78452317 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.76944582 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.75055139 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.66219064 |
| 24 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.64687034 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63806933 |
| 26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.63447754 |
| 27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.53654446 |
| 28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.51723969 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.50648741 |
| 30 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.47641578 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.45275957 |
| 32 | Insulin secretion_Homo sapiens_hsa04911 | 1.38325923 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.38294630 |
| 34 | Axon guidance_Homo sapiens_hsa04360 | 1.36709295 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.34681699 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.34158388 |
| 37 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.32501019 |
| 38 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30072881 |
| 39 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.22475358 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21279516 |
| 41 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.20657134 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 1.20653013 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 1.19948887 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15844489 |
| 45 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.11038837 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08835090 |
| 47 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04573825 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04038792 |
| 49 | Colorectal cancer_Homo sapiens_hsa05210 | 1.02230249 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01182660 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.97536349 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97109633 |
| 53 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.96478843 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95547705 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95289930 |
| 56 | Adherens junction_Homo sapiens_hsa04520 | 0.93995285 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 0.93011155 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 0.92652470 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.91993759 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90009293 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88496715 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.87149277 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87009068 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.86820856 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86198712 |
| 66 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86102681 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86083618 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83906475 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83571764 |
| 70 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.82688034 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82414371 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.82333481 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81274372 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.76498977 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75940064 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72708733 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72218119 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70603869 |
| 79 | Pathways in cancer_Homo sapiens_hsa05200 | 0.69461409 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69299921 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68626156 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68540946 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.68142084 |
| 84 | Melanogenesis_Homo sapiens_hsa04916 | 0.68088049 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64357250 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64285213 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64076940 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63648478 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63592855 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.63404815 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63189618 |
| 92 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60194217 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59434414 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59312569 |
| 95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58795868 |
| 96 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.58260959 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.58071480 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56529242 |
| 99 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56117032 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55509742 |
| 101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54734589 |
| 102 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53832881 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53749065 |
| 104 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52609465 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52575546 |
| 106 | Alcoholism_Homo sapiens_hsa05034 | 0.50301781 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50058737 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49862256 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.49388091 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49046758 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48528616 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48487101 |
| 113 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48090492 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47835913 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47134981 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45506310 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45318113 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.44224191 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44188929 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43731959 |
| 121 | Melanoma_Homo sapiens_hsa05218 | 0.42681846 |
| 122 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40991426 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40688536 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40030999 |
| 125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39555851 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39256741 |
| 127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37490248 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36731319 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36358297 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36051445 |
| 131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34399941 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34188729 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33718915 |
| 134 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33695493 |

